Fabry disease: biochemical, pathological and structural studies of the α-galactosidase A with E66Q amino acid substitution.

Recently, male subjects harboring the c.196G>C nucleotide change which leads to the E66Q enzyme having low α-galactosidase A (GLA) activity have been identified at an unexpectedly high frequency on Japanese and Korean screening for Fabry disease involving dry blood spots and plasma/serum samples. Individuals with the E66Q enzyme have been suspected to have the later-onset Fabry disease phenotype leading to renal and cardiac disease. However, there has been no convincing evidence for this. To determine whether c.196G>C (E66Q) is disease-causing or not, we performed biochemical, pathological and structural studies. It was predicted that the E66Q amino acid substitution causes a small conformational change on the molecular surface of GLA, which leads to instability of the enzyme protein. However, biochemical studies revealed that subjects harboring the E66Q enzyme exhibited relatively high residual enzyme activity in white blood cells, and that there was no accumulation of globotriaosylceramide in cultured fibroblasts or an increased level of plasma globotriaosylsphingosine in these subjects. An electron microscopic examination did not reveal any pathological changes specific to Fabry disease in biopsied skin tissues from a male subject with the E66Q enzyme. These results strongly suggest that the c.196G>C is not a pathogenic mutation but is a functional polymorphism.
AuthorsTadayasu Togawa, Takahiro Tsukimura, Takashi Kodama, Toshie Tanaka, Ikuo Kawashima, Seiji Saito, Kazuki Ohno, Tomoko Fukushige, Takuro Kanekura, Atsushi Satomura, Duk-Hee Kang, Beom Hee Lee, Han-Wook Yoo, Kent Doi, Eisei Noiri, Hitoshi Sakuraba
JournalMolecular genetics and metabolism (Mol Genet Metab) Vol. 105 Issue 4 Pg. 615-20 (Apr 2012) ISSN: 1096-7206 [Electronic] United States
PMID22305854 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier Inc. All rights reserved.
Chemical References
  • Trihexosylceramides
  • globotriaosylceramide
  • alpha-Galactosidase
  • Aged
  • Aged, 80 and over
  • Amino Acid Substitution
  • Asian Continental Ancestry Group
  • Cells, Cultured
  • Child, Preschool
  • DNA Mutational Analysis
  • Fabry Disease (enzymology, genetics, pathology)
  • Fibroblasts (cytology, enzymology)
  • Heterozygote
  • Humans
  • Immunoblotting
  • Male
  • Microscopy, Electron
  • Middle Aged
  • Models, Molecular
  • Mutation (genetics)
  • Phenotype
  • Real-Time Polymerase Chain Reaction
  • Skin (cytology, enzymology)
  • Trihexosylceramides (blood)
  • alpha-Galactosidase (chemistry, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: